A study by Katayama and colleagues in patients with type 2 diabetes has shown that albuminuria is more effectively controlled by combination therapy with the angiotensin II receptor blocker ...

In another such trial (VALUE), researchers randomized 15,245 hypertensive patients (minimum age, 50; mean BP, 155/87 mm Hg) in 31 countries to receive the angiotensin-receptor blocker valsartan or ...

Adverse events were more likely to cause discontinuation of the valsartan plus captopril combination (9%) than captopril (7.7%) or valsartan (5.8%). These results strengthen the basis of ARB use ...